Overview
Horse vaccine from Boehringer Ingelheim as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis and tetanus, as an aid in the prevention of viremia and mortality, as an aid in the reduction of severity of clinical disease caused by West Nile Virus, as an aid in the reduction of respiratory disease caused by equine herpes virus types 1 and 4 (EHV-1 and EHV-4), and as an aid in the reduction of respiratory disease and shedding caused by A2 equine influenza virus.
For vaccination of healthy horses 4 months of age or older. Duration of immunity against equine influenza is at least 6 months, and against West Nile Virus is at least 12 months.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 124.
Learn More About Equine Core Vaccines
For vaccination of healthy horses 4 months of age or older. Duration of immunity against equine influenza is at least 6 months, and against West Nile Virus is at least 12 months.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 124.
Learn More About Equine Core Vaccines
Manufacturer Label
Safety Data Sheet (SDS)
Vetera Gold XP Horse Vaccine
15366
7-way protection with just one dose
Horse vaccine from Boehringer Ingelheim as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis and tetanus, as an aid … Read More Read More
Features & Benefits
- Contains the equine influenza virus (EIV) strains most likely to infect horses: Richmond/07, Ohio/03 and Kentucky/WNV protection for at least 12 months in horses as young as 4 months
- Carbimmune™ adjuvant system minimizes injection site reactions
Quantity
MAP
Price Each
1 dose w/syringe & needle
Item #15366-1
Case Quantity: 10
Weight: 0.10 lbs
Overview
Horse vaccine from Boehringer Ingelheim as an aid in the prevention of disease caused by Eastern and Western encephalomyelitis and tetanus, as an aid in the prevention of viremia and mortality, as an aid in the reduction of severity of clinical disease caused by West Nile Virus, as an aid in the reduction of respiratory disease caused by equine herpes virus types 1 and 4 (EHV-1 and EHV-4), and as an aid in the reduction of respiratory disease and shedding caused by A2 equine influenza virus.
For vaccination of healthy horses 4 months of age or older. Duration of immunity against equine influenza is at least 6 months, and against West Nile Virus is at least 12 months.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 124.
Learn More About Equine Core Vaccines
For vaccination of healthy horses 4 months of age or older. Duration of immunity against equine influenza is at least 6 months, and against West Nile Virus is at least 12 months.
Dosage: 1 ml IM, repeat in 3-4 weeks. Revaccinate annually.
Anaphylactoid reactions may occur. Antidote: Epinephrine.
U.S. Lic. No. 124.
Learn More About Equine Core Vaccines
Manufacturer Label
Safety Data Sheet (SDS)
PBS Animal Health 5-Point Promise – Vaccines Done RIGHT!
Shipping Information for Temperature Sensitive Items
(Vaccines and Other Refrigerated Items)
Product Reviews